Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population

INTRODUCTION: We investigated the efficacy and toxicity of pembrolizumab in patients with mesothelioma from a real-world Australian population. We aimed to determine clinical factors and predictive biomarkers that could help select patients who are likely to benefit from pembrolizumab. METHOD: Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadzada, Tamkin, Cooper, Wendy A., Holmes, Mikaela, Mahar, Annabelle, Westman, Helen, Gill, Anthony J., Nordman, Ina, Yip, Po Yee, Pal, Abhijit, Zielinski, Rob, Pavlakis, Nick, Nagrial, Adnan, Daneshvar, Dariush, Brungs, Daniel, Karikios, Deme, Aleksova, Vesna, Burn, Juliet, Asher, Rebecca, Grau, Georges E., Hosseini-Beheshti, Elham, Reid, Glen, Clarke, Stephen, Kao, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474198/
https://www.ncbi.nlm.nih.gov/pubmed/34589956
http://dx.doi.org/10.1016/j.jtocrr.2020.100075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474198/
https://www.ncbi.nlm.nih.gov/pubmed/34589956
http://dx.doi.org/10.1016/j.jtocrr.2020.100075

Ejemplares similares